biomerica.png
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
February 21, 2024 08:19 ET | Biomerica, Inc.
IRVINE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, proudly announces the...
biomerica.png
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
January 23, 2024 08:19 ET | Biomerica, Inc.
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built...
biomerica.png
Biomerica Reports Second Quarter 2024 Financial Results
January 16, 2024 08:19 ET | Biomerica, Inc.
Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023.Loss per shares narrows to $0.09 per share from $0.12 per share...
RP_logo_1.1_BlueBg-2080 (1).png
Medical Device Technologies Market size growing with a CAGR of 18.50%: Growth Outlook from 2022 to 2030, projecting market trends analysis by Application, Regional Outlook, and Revenue
December 18, 2023 10:40 ET | PRIMEIQ RESEARCH (OPC) PRIVATE LIMITED
New York, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Market Overview and Report Coverage The Medical Device Technologies market research reports provide comprehensive information on the market conditions...
biomerica.png
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
December 18, 2023 07:47 ET | Biomerica, Inc.
Over 80% of gastric cancers are attributed to H. pylori bacterial infection Gastric cancer is the third most common cause of cancer related death in the world ...
biomerica.png
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
November 10, 2023 08:19 ET | Biomerica, Inc.
IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th...
biomerica.png
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
November 08, 2023 08:19 ET | Biomerica, Inc.
Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rolloutVeteran Vice President of Sales and National...
biomerica.png
REPEAT - Biomerica Reports First Quarter 2024 Financial Results
October 13, 2023 13:10 ET | Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024
biomerica.png
Biomerica Reports First Quarter 2024 Financial Results
October 13, 2023 06:39 ET | Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024
biomerica.png
Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test
September 26, 2023 08:19 ET | Biomerica, Inc.
IRVINE, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Dubai government has officially approved insurance reimbursement for the EZ...